Saturday, October 3, 2026

Aspen Group Stock Bearish By 23% In The Last 5 Sessions

Aspen Group Stock Bearish By 23% In The Last 5 Sessions

(VIANEWS) - Shares of Aspen Group (NASDAQ: ASPU) slid by a staggering 23.6% in 5 sessions from $0.22 at -23.6, to $0.17 at 20:26 EST on Sunday, after four sequential sessions in a row of losses. NASDAQ is falling 1.76% to $11,138.89, after two consecutive sessions in a row of losses.

Aspen Group's last close was $0.17, 91.18% under its 52-week high of $1.91.

About Aspen Group

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.383.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -28.28%.

Volume

Today's last reported volume for Aspen Group is 128474 which is 90.21% below its average volume of 355861.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aspen Group's stock is considered to be overbought (>=80).

Volatility

Aspen Group's last week, last month's, and last quarter's current intraday variation average was a positive 1.60%, a negative 0.22%, and a positive 6.33%.

Aspen Group's highest amplitude of average volatility was 5.83% (last week), 5.47% (last month), and 6.33% (last quarter).

Moving Average

Aspen Group's worth is way under its 50-day moving average of $0.26 and way below its 200-day moving average of $0.58.

More news about Aspen Group (ASPU).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com